US PTAB Patent Cases
8,574 decisions indexed
Page 264 of 286 · 8,574 total
Samsung Electronics Co. Ltd. et al. v.Maxell, Ltd.
Samsung successfully secured institution in this IPR against Maxell, challenging numerous claims of patent 11445241. The Board found sufficient evidence regarding prior art combinations involving N93, Dua, and Herle. This decision moves the dispute toward a full trial on obviousness grounds.
Nokia of America Corporation et al. v.Iarnach Technologies Limited
Nokia of America Corporation successfully petitioned the PTAB to challenge Iarnach Technologies Limited's patent (9806892) on grounds of obviousness in passive optical networks (PON). The Board found a reasonable likelihood of unpatentability for several claims based on combinations of prior art references.
Nokia of America Corporation et al. v.Iarnach Technologies Limited
Nokia of America Corporation et al.'s IPR petition against Iarnach Technologies Limited was denied by the PTAB, preventing trial on claims 1-11. The Board found that the combination of prior art references (G.984.3 and Khermosh) did not sufficiently teach or suggest the claimed method for managing upstream burst overhead parameters in PON systems.
Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC
The PTAB denied institution of an IPR challenging five claims related to channel estimation in MIMO systems. The Board found that the petitioner failed to demonstrate a reasonable likelihood of prevailing against obviousness grounds over multiple prior art references.
Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC
Samsung Electronics successfully petitioned for IPR against Empire Technology Development's patent, arguing that the claims are obvious over prior art. The Board preliminarily adopted a broad definition of 'idle power consumption,' setting the stage for a detailed examination of technical combination possibilities.
Juniper Networks, Inc. v.Portsmouth Network Corporation
The PTAB granted institution for an IPR concerning network reconfiguration protocols, finding a reasonable likelihood of prevailing on the grounds of obviousness (103). The patent relates to methods for rapid link failure recovery in Switching/Routing Protocols (STP).
Juniper Networks, Inc. v.Orckit Corporation
Juniper Networks' attempt to challenge Orckit's patent was denied by the PTAB. The Board cited General Plastic factors, finding that the claims were materially similar to those previously reviewed and Petitioner had prior knowledge of the asserted prior art.
BOTE, LLC v.STEAMBOAT PADDLESPORTS, LLC.
The PTAB granted institution of IPR for 20 claims covering inflatable paddle boards. The Board found a reasonable likelihood that the challenger, BOTE, LLC, would prevail on obviousness grounds over prior art references like Hoffmann and Hoge.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc. successfully secured institutional status in an IPR against DexCom, Inc., regarding continuous glucose monitoring systems. The Board found sufficient evidence that prior art references anticipate or render obvious key claims related to transcutaneous sensors and drift profiles.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc. successfully petitioned to institute IPR against DexCom, Inc.'s glucose monitoring patent (11020031). The Board found sufficient evidence for trial on 22 claims based on anticipation and obviousness over prior art from Zhang and Shin.
smaXtec Inc. et al. v.ST Reproductive Technologies, LLC et al.
The PTAB granted institution for the IPR challenge against a patent covering animal management systems using RFID technology. The Petitioner successfully argued that prior art references, including Trevarthen and Laitinen/Buchanan/Liao, provided sufficient motivation to combine elements of the challenged claims.
BOTE, LLC v.STEAMBOAT PADDLESPORTS, LLC
BOTE, LLC successfully petitioned to institute IPR against Twitch LLC regarding U.S. Patent No. 10,479,458 for inflatable paddle boards. The Board found a reasonable likelihood that the patent's claims would be obvious over prior art references.
Voltage, LLC et al. v.Shoals Technologies Group, LLC
Voltage, LLC failed its IPR challenge against Shoals Technologies Group regarding photovoltaic connectors. The PTAB denied the petition, finding that the combination of prior art references lacked sufficient motivation to render the claims obvious under 35 U.S.C. § 103.
smaXtec Inc. et al. v.ST Reproductive Technologies, LLC et al.
The PTAB has instituted an IPR proceeding challenging the validity of claims in patent 9844206, focusing on obviousness (35 U.S.C. § 103). The Petitioner successfully demonstrated a reasonable likelihood of prevailing by presenting strong arguments regarding prior art combination and claim construction.
Voltage, LLC et al. v.Shoals Technologies Group, LLC
Voltage, LLC's IPR petition against Shoals Technologies Group, LLC was denied by the PTAB, finding that the petitioner failed to demonstrate a reasonable likelihood of prevailing on any claim. The dispute centered on obviousness grounds (35 U.S.C. § 103) regarding solar power interconnection systems.
Biofrontera AG et al. v.Sun Pharmaceutical Industries, Inc.
The PTAB denied an IPR challenge brought by Biofrontera AG against Sun Pharmaceutical Industries regarding photodynamic therapy illuminators. The Board found the petitioner failed to demonstrate a reasonable likelihood of prevailing on obviousness grounds (103).
Reed Semiconductor Corporation v.Monolithic Power Systems, Inc.
The PTAB denied institution for Reed Semiconductor Corporation's IPR against Monolithic Power Systems, Inc., finding Petitioner failed to adequately map claims onto prior art references. The denial was based on insufficient explanation regarding specific functional limitations in the voltage converter technology.
ENS Labs Ltd. v.Unstoppable Domains Inc.
ENS Labs Ltd.'s IPR challenge against Unstoppable Domains Inc. was denied by the PTAB, primarily because the petitioner failed to prove that key prior art documentation qualified as publicly accessible under 35 U.S.C. § 102. The Board found the evidence of public accessibility insufficient to support the obviousness grounds asserted across multiple claims.
Ericsson Inc. et al. v.XR COMMUNICATIONS LLC
The PTAB instituted trial in an IPR proceeding concerning MIMO/Beamforming antenna technology. The Board found sufficient evidence to suggest that several challenged claims are unpatentable over the prior art, specifically Trigui and Rudrapatna. This decision moves the dispute forward toward a full evidentiary hearing on obviousness grounds.
WIZ, Inc. v.Orca Security Ltd.
WIZ, Inc. successfully navigated the institution phase of an IPR against Orca Security Ltd., demonstrating a reasonable likelihood of prevailing on its obviousness claims (35 U.S.C. § 103). The Board preliminarily agreed with Wiz's claim construction arguments regarding snapshot analysis and API usage based on prior art references.
WIZ, Inc. v.Orca Security Ltd.
WIZ, Inc. successfully convinced the PTAB to institute an IPR against Orca Security Ltd.'s patent covering virtualization and cloud security. The Board found sufficient evidence that the combination of prior art references would render the claims obvious, leading to a trial.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom regarding claims related to remote patient monitoring and glucose management. The PTAB found sufficient evidence that the petitioner met its burden of demonstrating a reasonable likelihood of prevailing on multiple grounds (102 and 103).
WIZ, Inc. v.Orca Security Ltd.
WIZ, Inc. successfully convinced the PTAB to institute its IPR against Orca Security Ltd.'s patent (11663031) in cybersecurity/cloud computing. The Board found a reasonable likelihood of success on multiple grounds of obviousness (103), particularly regarding the combination of prior art references Veselov and Price.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc. successfully petitioned to institute IPR proceedings against DexCom, Inc.'s patent (11510625) regarding transcutaneous analyte measurement systems. The Board found a reasonable likelihood of prevailing on unpatentability based on alleged anticipation by prior art reference Pace for at least Claim 1.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
The PTAB denied Abbott's second IPR petition against DexCom's '625 patent. The Board ruled that the petitioner failed to demonstrate any material difference in grounds compared to a previously instituted review.
Google LLC et al. v.EyesMatch Ltd.
Google LLC et al. successfully petitioned for institution of IPR against EyesMatch Ltd.'s patent 8982109, challenging claims based on obviousness (35 U.S.C. § 103). The Board declined to deny institution despite arguments regarding parallel district court litigation.
Trove Brands, LLC et al. v.Vista Outdoor Operations LLC
The PTAB granted institution of IPR for Trove Brands against CamelBak's patent 8905252, finding that the petitioner demonstrated a reasonable likelihood of proving unpatentability over Samartgis and Leoncavallo.
Samsung Display Co., Ltd. et al. v.Pictiva Displays International Ltd.
Samsung Display Co., Ltd.'s IPR petition against Pictiva Displays International Ltd. was denied by the PTAB. The Board found that the petition lacked compelling merits and determined the dispute was better suited for District Court resolution due to complex claim construction issues.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson Technology Limited successfully convinced the PTAB to institute trial against Omachron Intellectual Property regarding patent 10478030, which covers surface cleaning apparatus. The Board found sufficient evidence of anticipation and obviousness across multiple claims (1-13) based on prior art references including Peter, Neroni, and Butler.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom for patent infringement related to remote patient monitoring and glucose technology. The Board found a reasonable likelihood of prevailing on multiple grounds, specifically finding that prior art combinations rendered key claims obvious under 35 U.S.C. § 103.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.